Experts in healthcare reimbursement and regulation,
providing customized consulting
and education services.

Training Programs

We bring the experts to you with a range of on-site education options and bootcamp style programs that teach how a firm grasp of the rules leads to operational excellence.

More information »

Audits & Assessments

Our team of specialized regulatory specialists can assist your organization in revving up your revenue cycle by auditing and assessing key processes for coding and billing.

More information »

Regulatory Monitoring

Our team is available for ongoing regulatory watchdog services that answer your questions and offer you the latest Medicare news, analysis and operational guidance.

More information »

Dec
01

November 17-24: CMS and OIG Issuances

Email This Post Print This Post

Frequently asked questions

On November 21, CMS issued 41 new/updated frequently asked questions related to Medicare fee-for-service payment.

View the frequently asked questions.

CMS selects A/B Medicare administrative contractor (MAC) for New England

On November 19, CMS announced its selection of National Heritage Insurance Corporation (NHIC) as the A/B MAC for Maine, Massachusetts, New Hampshire, Rhode Island, and Vermont. As the A/B MAC contractor, NHIC will immediately begin implementation activities and will assume full responsibility for the claims processing work in its five-state jurisdiction no later than May 2009.

View the CMS press release.

OIG issues report on Medicare billing for oxaliplatin at Franklin Memorial Hospital during calendar years (CY) 2004 and 2005

On November 19, the OIG issued a report in which it determined that Franklin Memorial billed Medicare incorrectly for oxaliplatin in CY 2004. These erroneous claims resulted in a net overbilling to Medicare of $97,968 for oxaliplatin furnished to hospital outpatients during CY 2004.

View the OIG report.

CMS issues proposed decision memo on surgery for diabetes

On November 17, CMS issued a proposed decision memo in which it proposed that type 2 diabetes mellitus is a comorbid condition related to obesity, as defined in NCD Manual 100.1 (Bariatric Surgery for Treatment of Morbid Obesity).

View the proposed decision memo.

View a related press release.

Leave a Reply